285 related articles for article (PubMed ID: 7749926)
1. What do dysfunctional serpins tell us about molecular mobility and disease?
Stein PE; Carrell RW
Nat Struct Biol; 1995 Feb; 2(2):96-113. PubMed ID: 7749926
[TBL] [Abstract][Full Text] [Related]
2. Serpins: the uncut version.
Goldsmith EJ; Mottonen J
Structure; 1994 Apr; 2(4):241-4. PubMed ID: 8087550
[TBL] [Abstract][Full Text] [Related]
3. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy.
Perkins SJ; Smith KF; Nealis AS; Haris PI; Chapman D; Bauer CJ; Harrison RA
J Mol Biol; 1992 Dec; 228(4):1235-54. PubMed ID: 1335516
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for serpin inhibitor activity.
Wright HT; Scarsdale JN
Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
[TBL] [Abstract][Full Text] [Related]
5. Alpha 1-antitrypsin deficiency. A conformational disease.
Carrell RW; Lomas DA; Sidhar S; Foreman R
Chest; 1996 Dec; 110(6 Suppl):243S-247S. PubMed ID: 8989158
[TBL] [Abstract][Full Text] [Related]
6. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles.
Janciauskiene S
Biochim Biophys Acta; 2001 Mar; 1535(3):221-35. PubMed ID: 11278163
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia.
Lomas DA; Lourbakos A; Cumming SA; Belorgey D
Biochem Soc Trans; 2002 Apr; 30(2):89-92. PubMed ID: 12023831
[TBL] [Abstract][Full Text] [Related]
8. Shape-shifting serpins--advantages of a mobile mechanism.
Huntington JA
Trends Biochem Sci; 2006 Aug; 31(8):427-35. PubMed ID: 16820297
[TBL] [Abstract][Full Text] [Related]
9. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
Whisstock J; Lesk AM; Carrell R
Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
[TBL] [Abstract][Full Text] [Related]
10. Structure and mechanism of action of serpins.
Gettins P; Patston PA; Schapira M
Hematol Oncol Clin North Am; 1992 Dec; 6(6):1393-408. PubMed ID: 1452519
[TBL] [Abstract][Full Text] [Related]
11. New insights into the structural basis of alpha 1-antitrypsin deficiency.
Lomas DA
QJM; 1996 Nov; 89(11):807-12. PubMed ID: 8977959
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop.
Wei A; Rubin H; Cooperman BS; Christianson DW
Nat Struct Biol; 1994 Apr; 1(4):251-8. PubMed ID: 7656054
[TBL] [Abstract][Full Text] [Related]
13. Biological implications of a 3 A structure of dimeric antithrombin.
Carrell RW; Stein PE; Fermi G; Wardell MR
Structure; 1994 Apr; 2(4):257-70. PubMed ID: 8087553
[TBL] [Abstract][Full Text] [Related]
14. Polymerisation underlies alpha1-antitrypsin deficiency, dementia and other serpinopathies.
Lomas DA; Belorgey D; Mallya M; Onda M; Kinghorn KJ; Sharp LK; Phillips RL; Page R; Crowther DC; Miranda E
Front Biosci; 2004 Sep; 9():2873-91. PubMed ID: 15353322
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of serpin dysfunction in disease.
Kaiserman D; Whisstock JC; Bird PI
Expert Rev Mol Med; 2006 Dec; 8(31):1-19. PubMed ID: 17156576
[TBL] [Abstract][Full Text] [Related]
16. Apical and non-polarized secretion of serpins from MDCK cells.
Vogel LK; Larsen JE
FEBS Lett; 2000 May; 473(3):297-302. PubMed ID: 10818229
[TBL] [Abstract][Full Text] [Related]
17. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
[TBL] [Abstract][Full Text] [Related]
18. C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease.
Beinrohr L; Harmat V; Dobó J; Lörincz Z; Gál P; Závodszky P
J Biol Chem; 2007 Jul; 282(29):21100-9. PubMed ID: 17488724
[TBL] [Abstract][Full Text] [Related]
19. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
20. Reversible inactivation of serpins at acidic pH.
Boudier C; Bousquet JA; Schauinger S; Michels B; Bieth JG
Arch Biochem Biophys; 2007 Oct; 466(2):155-63. PubMed ID: 17765197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
